Results 231 to 240 of about 1,041,138 (268)

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

open access: yesArthritis Care &Research, Accepted Article.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti   +19 more
wiley   +1 more source

Environmental surveillance of bacteria in a new intensive care unit using plate sweeps. [PDF]

open access: yesMicrob Genom
McMurray-Jones A   +4 more
europepmc   +1 more source

Intensive Care to Facilitate Organ Donation: Insights From the French Guidelines. [PDF]

open access: yesTranspl Int
Le Dorze M   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy